53.4 F
New York
Wednesday, November 25, 2020

Marimed Inc (OTCMKTS:MRMD) Gets Rolling on the Strategic Investment Side

Must read

Apartment Investment and Management Company (NYSE:AIV) on the Path to Profitability

Apartment Investment and Management Company (AIV) shares are trading at higher $31.70 and the avg recommendation for the stock is Moderate Buy, while the...

Can We Expect More Volatility From Cree Inc. (CREE)?

Cree Inc. (CREE) shares are trading at higher $89.75 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Companhia Siderurgica Nacional (NYSE:SID) Recent Earnings Shows Major Promise

Companhia Siderurgica Nacional (SID) shares are trading at higher $4.20 and the avg recommendation for the stock is Hold, while the current analyst price...

The Forecast Just Changed on Air Lease Corporation (NYSE:AL)

Air Lease Corporation (AL) shares are trading at higher $39.81 and the avg recommendation for the stock is Strong Buy, while the current analyst...

One of the true leadership plays in the market over the past year – and one that has perhaps slipped through the cracks for many cannabis stock traders – is Marimed Inc (OTCMKTS:MRMD). The company, along with GenCanna Global Inc., just announced that the companies have entered into an agreement whereby MariMed has invested $30 million in GenCanna, and the companies have created a strategic partnership, including a long-term supply agreement.

According to the release, the partnership expands MariMed’s robust product development capabilities and strengthens GenCanna’s position as a global leader in the Hemp CBD industry.

Marimed Inc (OTCMKTS:MRMD) is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities. MariMed’s team has developed state-of-the-art, regulatory-compliant legal cannabis facilities in multiple states.

These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. MariMed is on the forefront of precision dosed cannabis medicine for the treatment of specific medical conditions. MariMed branded products are being licensed and distributed in legal cannabis states across the country.

We have licensed Tikun Olam world renown Israeli cannabis genetics with 5 years of clinical data for our Delaware managed facility.

Moreover, MariMed Inc. provides consulting services for the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities. The company also develops and manages facilities for the cultivation, production, and dispensing of legal cannabis and cannabis-infused products under the Kalm Fusion brand name. In addition, it offers legal, accounting, human resources, and other corporate and administrative services.

As of December 31, 2017, it developed and managed six operating cannabis facilities for clients in Delaware, Illinois, Nevada, and Maryland. MariMed Inc. was incorporated in 2011 and is based in Newton, Massachusetts.

According to company materials, “MariMed designs, develops, finances, and optimizes the success of medical cannabis cultivation, production, and dispensary facilities through its validated management. MariMed’s team has developed or is in the process of developing state-of-the-art regulatory-compliant facilities in DE, IL, NV, MD, MA, and RI. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. In addition, MariMed is on the forefront of precision dosed branded products for the treatment of specific medical symptoms. MariMed currently distributes its branded products in select states and is expanding licensing and distribution to numerous additional states encompassing thousands of dispensaries.”

Find out when $MRMD reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, MRMD just announced, along with GenCanna Global Inc., just announced that the companies have entered into an agreement whereby MariMed has invested $30 million in GenCanna, and the companies have created a strategic partnership, including a long-term supply agreement. In all, we’ve witnessed -3% stripped out of shares for shareholders of the name during the trailing month.

In addition, the stock has seen interest climb, with an increase in recent trading volume of 56% over the long run average.

“MariMed’s renowned product development expertise, combined with GenCanna’s leadership position in premium Hemp CBD, will enable us to expand the Hemp CBD product category by creating compelling new consumer brands, and by developing powerful distribution channels,” said Robert Fireman, President and CEO of MariMed. Mr. Fireman continued,

“GenCanna shares our values – including our best practices values in producing premium-quality, consistent, and compliant Hemp CBD oils and extracts. We believe many of the nation’s leading retailers will soon provide Hemp CBD products to their customers, in response to popular demand. MariMed will only purchase from companies who meet those standards. This investment and partnership positions our two companies — working together – to become a trusted leader in the rapidly-growing Hemp CBD sector.”

Currently trading at a market capitalization of $921.48M, MRMD has a significant war chest ($5.1M) of cash on the books, which must be weighed relative to about $16.1M in total current liabilities. MRMD is pulling in trailing 12-month revenues of $8.3M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 81.2%. We will update the story again as soon as developments transpire. Sign-up for continuing coverage on shares of $MRMD stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $MRMD, either long or short, and we have not been compensated for this article.

Latest article

MasTec Inc. (NYSE:MTZ) is Gaining Momentum on Earnings Catalyst

MasTec Inc. (MTZ) shares are trading at higher $59.23 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

Is the Rough Ride Over for Signet Jewelers Limited (SIG)

Signet Jewelers Limited (SIG) shares are trading at higher $31.20 and the avg recommendation for the stock is Hold, while the current analyst price...

PDL BioPharma Inc. (NASDAQ:PDLI) Recent Earnings Shows Major Promise

PDL BioPharma Inc. (PDLI) shares are trading at higher $2.50, while the current analyst price target stands at $2.50. To add more color to...

Will Pentair plc (PNR) Find a Support Level Soon?

Pentair plc (PNR) shares are trading at higher $54.09 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Inuvo Inc. (AMEX:INUV) Finding Zero Support

Inuvo Inc. (INUV) shares are trading at lower $0.36 and the avg recommendation for the stock is Moderate Buy. To add more color to...